| Medical and Health Sciences | 2021-2025 | 676 | US 229 | 99.85 |
| Pulmonary and Respiratory Medicine | Lifetime | 72 | US 37 | 99.90 |
| Rheumatology | Lifetime | 265 | US 117 | 98.91 |
| Pathology and Forensic Medicine | Lifetime | 536 | US 251 | 97.73 |
| Medical Genetics | Lifetime | 622 | US 309 | 93.42 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 40 | US 14 | 99.82 |
| Rheumatology | 2021-2025 | 75 | US 20 | 98.09 |
| Pathology and Forensic Medicine | 2021-2025 | 543 | US 171 | 69.49 |
| Vasculitis and related conditions | Lifetime | 4 | US 2 | 99.92 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 9 | US 5 | 99.71 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 3 | US 1 | 99.84 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 17 | US 10 | 99.61 |
| Systemic Sclerosis and Related Diseases | Lifetime | 45 | US 18 | 99.45 |
| Urticaria and Related Conditions | Lifetime | 42 | US 17 | 99.38 |
| Renal Diseases and Glomerulopathies | Lifetime | 159 | US 67 | 98.96 |
| Systemic Lupus Erythematosus Research | Lifetime | 440 | US 159 | 98.60 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 85 | US 35 | 97.79 |
| Eosinophilic Disorders and Syndromes | Lifetime | 295 | US 144 | 97.70 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 342 | US 149 | 97.63 |
| Dermatologic Treatments and Research | Lifetime | 406 | US 179 | 96.13 |
| Inflammasome and immune disorders | Lifetime | 587 | US 163 | 95.12 |
| Mast cells and histamine | Lifetime | 663 | US 222 | 94.48 |
| Autoimmune and Inflammatory Disorders | Lifetime | 376 | US 119 | 94.74 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 383 | US 89 | 89.84 |
| Pathogenesis and Treatment of Hiccups | Lifetime | 546 | US 191 | 62.88 |
| Vasculitis and related conditions | 2021-2025 | 2 | US 1 | 99.92 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 4 | US 2 | 99.42 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 6 | US 3 | 99.01 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 45 | US 14 | 96.92 |
| Urticaria and Related Conditions | 2021-2025 | 75 | US 17 | 96.55 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 92 | US 51 | 95.96 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 444 | US 129 | 92.29 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 710 | US 132 | 91.32 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 114 | US 26 | 87.08 |
| Inflammasome and immune disorders | 2021-2025 | 592 | US 99 | 86.50 |
| Eosinophilic Esophagitis | 2021-2025 | 990 | US 305 | 82.05 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 203 | US 40 | 73.45 |
